Lanxess (ETR:LXS) has been given a €64.00 ($74.42) target price by stock analysts at Morgan Stanley in a research report issued on Friday, October 12th. The firm presently has a “neutral” rating on the stock. Morgan Stanley’s price objective would suggest a potential upside of 11.54% from the stock’s previous close.
LXS has been the subject of a number of other reports. Jefferies Financial Group set a €69.00 ($80.23) price objective on Lanxess and gave the stock a “neutral” rating in a research report on Thursday, August 2nd. Nord/LB set a €74.00 ($86.05) target price on Lanxess and gave the company a “neutral” rating in a research report on Wednesday, August 8th. Baader Bank set a €65.00 ($75.58) target price on Lanxess and gave the company a “sell” rating in a research report on Thursday, August 2nd. Deutsche Bank set a €68.00 ($79.07) price objective on Lanxess and gave the stock a “neutral” rating in a research report on Friday, September 21st. Finally, UBS Group set a €76.00 ($88.37) price objective on Lanxess and gave the stock a “buy” rating in a research report on Thursday, August 9th. Three analysts have rated the stock with a sell rating, twelve have assigned a hold rating and nine have issued a buy rating to the stock. Lanxess currently has a consensus rating of “Hold” and an average target price of €73.67 ($85.67).
Shares of ETR:LXS opened at €57.38 ($66.72) on Friday. Lanxess has a 12-month low of €59.89 ($69.64) and a 12-month high of €74.50 ($86.63).
LANXESS Aktiengesellschaft, a specialty chemicals company, develops, manufactures, and markets chemical intermediates, specialty chemicals, and plastics worldwide. It operates in five segments: Advanced Intermediates, Specialty Additives, Performance Chemicals, Engineering Materials, and ARLANXEO. The Advanced Intermediates segment offers high-grade intermediates for the agrochemical and coating industries; fine chemicals as precursors and intermediates for the pharmaceutical, agrochemical, and specialty chemical industries; customer-specific specialties; organometallics; and tire chemicals.
Recommended Story: Understanding Compound Annual Growth Rate (CAGR)
Receive News & Ratings for Lanxess Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lanxess and related companies with MarketBeat.com's FREE daily email newsletter.